Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 27:16:2843-2849.
doi: 10.2147/OPTH.S382499. eCollection 2022.

Comparison of Dose Increments of Botulinum Toxin A with Surgery as Primary Treatment for Infantile Esotropia and Partially Accommodative Esotropia

Fatemah T AlShamlan  1 , Fatimah Alghazal  1
Affiliations

Comparison of Dose Increments of Botulinum Toxin A with Surgery as Primary Treatment for Infantile Esotropia and Partially Accommodative Esotropia

Fatemah T AlShamlan et al. Clin Ophthalmol. .

Abstract

Purpose: To compare the effect of increment dose of botulinum toxin (BTX) injection in correlation to the angle of deviation to bilateral medial rectus recession (BMR) in infantile esotropia and partially accommodative esotropia (PAET).

Methods: This was a retrospective study that included pediatric patients ≤16 years old with infantile esotropia and PAET at Dhahran Eye Specialist Hospital (DESH) from 2014 till 2021 treated with increment dose of BTX or BMR. A successful outcome is defined as ocular alignment within 10 PD of deviation after 1-3 BTX injections or one surgery with a minimum follow-up of 6 months.

Results: Of 177 patients, 101 patients received BTX treatment for either infantile esotropia (n = 37) or PAET (n = 64) and 76 patients underwent BMR for either infantile ET (n = 25) or PAET (n = 51). BTX showed a higher success rate than BMR {65.3% vs 55.3% (p = 0.174)}. In patients with infantile esotropia, the success rate was comparable between BTX group and BMR group {40.5% vs 52% (p = 0.440)}. However, the success rate was statistically significantly higher in BTX group in compare to BMR group {79.7% vs 56.9% (p = 0.014)}. Consecutive exotropia was 0% in BTX group and 9.2% in BMR group (p = 0.002).

Conclusion: The increment dose of BTX injection is comparable to surgery in patients with infantile esotropia but superior to the routine surgery in patients with PAET. BTX has the advantage of a shorter procedure duration, lower costs, less exposure to general anesthesia and being minimally invasive intervention.

Keywords: botulinum toxin; esotropia; infantile esotropia; partially accommodative esotropia.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Treatment outcomes.
Figure 2
Figure 2
Treatment outcomes per diagnosis.
See this image and copyright information in PMC

References

    1. Zou YC, Liu L. The management of childhood esotropia with hyperopia. Curr Med Res Opin. 2011;27(4):731–735. PMID: 21265594. doi:10.1185/03007995.2011.552973 - DOI - PubMed
    1. Mohney BG. Common forms of childhood strabismus in an incidence cohort. Am J Ophthalmol. 2007;144(3):465–467. PMID: 17765436. doi:10.1016/j.ajo.2007.06.011 - DOI - PubMed
    1. Rowe FJ, Noonan CP. Botulinum toxin for the treatment of strabismus. Cochrane Database Syst Rev. 2017;3(3):CD006499. PMID: 28253424; PMCID: PMC6464099. doi:10.1002/14651858.CD006499.pub4 - DOI - PMC - PubMed
    1. Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc. 1981;79:734–770. PMID: 7043872; PMCID: PMC1312202. - PMC - PubMed
    1. Al Taisan A, Al Shamlan F, Al Mulhim A, Alsomali I, Al Owaifeer A. Botulinum toxin; indications, success rates and complications in the management of horizontal strabismus in Saudi Arabia. J Clin Ophthalmol. 2018;2(1). doi:10.35841/clinical-ophthalmology.2.1.32-37 - DOI

LinkOut - more resources